TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Biokraft Stockholm AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
119,623
|
127,530
|
121,911 |
Financial expenses |
0
|
518
|
1,227 |
Earnings before taxes |
23,403
|
25,574
|
14,738 |
EBITDA |
22,284
|
26,103
|
17,403 |
Total assets |
90,590
|
97,312
|
156,869 |
Current assets |
54,392
|
60,122
|
39,074 |
Current liabilities |
51,143
|
55,735
|
32,484 |
Equity capital |
39,447
|
41,577
|
45,868 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
43.5%
|
42.7%
|
29.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
19.6%
|
20.1%
|
12.1% |
Return on assets (ROA) |
25.8%
|
26.8%
|
10.2% |
Current ratio |
106.4%
|
107.9%
|
120.3% |
Return on equity (ROE) |
59.3%
|
61.5%
|
32.1% |
Change turnover |
-7,907
|
5,619
|
-3,559 |
Change turnover % |
-6%
|
5%
|
-3% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.